Scientifica,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Respiratory
viral
infections,
including
influenza
and
coronaviruses,
present
significant
health
risks
worldwide.
The
recent
COVID‐19
pandemic
highlights
the
urgent
need
for
novel
effective
antiviral
agents.
host
cell
protease,
transmembrane
serine
protease
2
(TMPRSS2),
facilitates
pathogenesis
by
playing
a
critical
role
in
invasion
disease
progression.
This
is
coexpressed
with
receptors
of
angiotensin‐converting
enzyme
(ACE2)
SARS‐CoV‐2
human
respiratory
tract
plays
activating
proteins
spreading.
TMPRSS2
activates
coronavirus
spike
(S)
protein
permits
membrane
fusion
entry
cleaving
virus
surface
glycoproteins.
It
also
hemagglutinin
(HA)
protein,
an
necessary
spread
virus.
inhibitors
can
reduce
propagation
morbidity
blocking
into
cells
reducing
spread,
inflammation,
severity.
review
examines
replication
pathogenicity.
offers
potential
avenues
to
develop
targeted
antivirals
inhibit
function,
suggesting
possible
focus
on
development.
Ultimately,
seeks
contribute
improving
public
outcomes
related
these
infections.
Mammalian Genome,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
The
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2)
infection
is
not
limited
to
the
respiratory
tract
as
receptors,
including
angiotensin-converting
enzyme
2
(ACE2),
are
expressed
across
many
tissues.
This
study
employed
a
new
conditional
mouse
model,
Rosa26creERT2/chACE2,
which
expresses
human
ACE2
(hACE2)
multiple
organs,
investigate
effects
of
SARS-CoV-2
beyond
system.
strain
demonstrated
susceptibility
in
dose
and
sex-dependent
manner,
showing
that
infected
male
mice
exhibited
more
severe
disease
outcomes,
significant
weight
loss,
pronounced
lung
pathology
dysfunction,
increased
mortality,
compared
females.
In
contrast
intratracheal
infection,
intranasal
virus
administration
facilitated
viral
spread
brain,
thereby
underscoring
nasal
route's
role
pathogenesis
neurological
manifestations.
Intranasal
also
led
innate
immune
system
activation
administration,
even
though
both
routes
activated
adaptive
response.
model
provides
valuable
tool
individual
tissues
or
use
multisystemic
approach,
it
advances
possibilities
for
preclinical
evaluation
antiviral
therapies
vaccine
strategies.
npj Vaccines,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Feb. 27, 2025
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
constantly
evolving
mutations
in
the
Spike
protein
to
evade
humoral
immunity.
Respiratory
tract
antiviral
IgA
antibodies
are
superior
circulating
IgG
preventing
SARS-CoV-2
infection.
However,
role
of
innate
immune
signals
required
for
induction
mucosal
against
infection
unknown.
Here
we
show
that
hamsters
recovered
from
ancestral
cross-protected
heterologous
alpha,
gamma,
delta,
and
omicron
BA.1
variants.
Intranasal
vaccination
with
an
inactivated
whole
virus
vaccine
completely
protects
In
addition,
intranasal
boost
mice
unadjuvanted
induces
robust
levels
anti-Spike
a
Furthermore,
our
findings
suggest
MyD88
MAVS
play
memory
response
following
booster
These
provide
useful
basis
development
cross-protective
vaccines
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 7, 2025
Abstract
The
TMPRSS2
cell
surface
protease
is
used
by
a
broad
range
of
respiratory
viruses
to
facilitate
entry
into
target
cells.
Together
with
ACE2,
represents
key
factor
for
SARS-CoV-2
infection,
as
mediates
cleavage
viral
spike
protein,
enabling
direct
fusion
the
envelope
host
membrane.
Since
start
COVID-19
pandemic,
has
gained
attention
therapeutic
inhibitors
which
would
inhibit
but
little
known
about
regulation,
particularly
in
types
physiologically
relevant
infection.
Here,
we
performed
an
unbiased
genome-wide
CRISPR-Cas9
library
screen,
together
targeted
at
epigenetic
modifiers
and
transcriptional
regulators,
identify
cellular
factors
that
modulate
expression
human
colon
epithelial
We
find
endogenous
regulated
Elongin
BC-VHL
complex
HIF
transcription
factors.
Depletion
B
or
treatment
cells
PHD
resulted
downregulation
inhibition
show
still
utilised
Omicron
variants
colonic
Our
study
enhances
our
understanding
regulation
ABSTRACT
Since
the
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
initiated
a
global
pandemic
resulting
in
an
estimated
775
million
infections
with
over
7
deaths,
it
has
become
evident
that
COVID-19
is
not
solely
pulmonary
disease.
Emerging
evidence
shown
that,
subset
patients,
certain
symptoms
−
including
chest
pain,
stroke,
anosmia,
dysgeusia,
diarrhea
and
abdominal
pain
–
all
indicate
role
vascular,
neurological
gastrointestinal
(GI)
pathology
disease
process.
Many
these
processes
persist
long
after
been
resolved,
‘long
COVID’
or
post-acute
sequelae
(PASC).
The
molecular
mechanisms
underlying
systemic
conditions
associated
remain
incompletely
defined.
Appropriate
animal
models
provide
method
understanding
at
system
level
through
study
progression,
tissue
pathology,
immune
response
to
pathogen
behavioral
responses.
However,
very
few
studies
have
addressed
PASC
whether
existing
hold
promise
for
studying
this
challenging
problem.
Here,
we
review
current
literature
on
cardiovascular,
GI
pathobiology
caused
by
along
established
manifestations
their
prospects
use
studies.
Our
aim
guidance
selection
appropriate
order
recapitulate
aspects
enhance
translatability
mechanistic
Scientifica,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Respiratory
viral
infections,
including
influenza
and
coronaviruses,
present
significant
health
risks
worldwide.
The
recent
COVID‐19
pandemic
highlights
the
urgent
need
for
novel
effective
antiviral
agents.
host
cell
protease,
transmembrane
serine
protease
2
(TMPRSS2),
facilitates
pathogenesis
by
playing
a
critical
role
in
invasion
disease
progression.
This
is
coexpressed
with
receptors
of
angiotensin‐converting
enzyme
(ACE2)
SARS‐CoV‐2
human
respiratory
tract
plays
activating
proteins
spreading.
TMPRSS2
activates
coronavirus
spike
(S)
protein
permits
membrane
fusion
entry
cleaving
virus
surface
glycoproteins.
It
also
hemagglutinin
(HA)
protein,
an
necessary
spread
virus.
inhibitors
can
reduce
propagation
morbidity
blocking
into
cells
reducing
spread,
inflammation,
severity.
review
examines
replication
pathogenicity.
offers
potential
avenues
to
develop
targeted
antivirals
inhibit
function,
suggesting
possible
focus
on
development.
Ultimately,
seeks
contribute
improving
public
outcomes
related
these
infections.